Syncona Limited Revenue and Competitors

London, UK

Location

N/A

Total Funding

VC/PE

Industry

Estimated Revenue & Valuation

  • Syncona Limited's estimated annual revenue is currently $3.5M per year.(i)
  • Syncona Limited's estimated revenue per employee is $67,308

Employee Data

  • Syncona Limited has 52 Employees.(i)
  • Syncona Limited grew their employee count by 6% last year.

Syncona Limited's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
Head Investor Relations and CommunicationsReveal Email/Phone
4
Group Finance DirectorReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Executive Assistant Office ManagerReveal Email/Phone
7
Senior Investor Relations and Communications ManagerReveal Email/Phone
8
Group F&A ManagerReveal Email/Phone
9
Associate PartnerReveal Email/Phone
10
Associate PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M28N/AN/AN/A
#2
$15M15915%$2.15BN/A
#3
$3.5M270%N/AN/A
#4
$3.5M8-11%N/AN/A
#5
$15M1947%N/AN/A
#6
$1.7M1017%N/AN/A
#7
$15M57-41%N/AN/A
#8
$15M55-8%N/AN/A
#9
N/A5640%N/AN/A
#10
$15M15-65%N/AN/A
Add Company

What Is Syncona Limited?

Syncona, is a leading FTSE 250 healthcare company focused on founding, building and funding a portfolio of global leaders in life science. Our vision is to build a sustainable, diverse portfolio of 15 - 20 companies focused on delivering transformational treatments to patients in truly innovative areas of healthcare, through which we are seeking to deliver strong risk-adjusted returns for shareholders. We take a long-term view, underpinned by a strategic capital base which enables us to maintain significant ownership positions in our companies and provides us with control and flexibility over the management of our portfolio. We believe we have the team, track record and skill-set to capture the superior returns available from commercialising exceptional science.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$3.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Syncona Limited News

2022-04-19 - Forcefield Therapeutics launches today following £5.5m ...

Chris Hollowood, Chief Investment Officer of Syncona Investment Management Limited, added: “The proteins identified through FunSel contain...

2022-04-19 - Forcefield raises £5.5M for protein-based heart attack drug

Forcefield Therapeutics Ltd. has arrived on the scene with £5.5 million ... comes from Syncona Ltd. Another Syncona company Purespring Ltd,...

2022-04-06 - Syncona News Headlines. SYNC Share News. Financial ...

Syncona's investee Anaveon receives good trial data. Mon, 11th Apr 2022 09:25. (Alliance News) - Syncona Ltd on Monday noted that its portfolio company...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.4M522%N/A
#2
$15.1M526%N/A
#3
$5.6M5227%N/A
#4
$10.6M5237%N/A
#5
$6.6M5213%$2M